LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,780,191
تعداد دریافت فایل اصل مقاله8,803,962
Malek, Abdolreza, Ghodsi, Alireza, Hamedi, Abdolkarim. (1401). The Negative Predictive Value of Harada Scoring for Coronary Artery Dilatation or Aneurysm in Children with Kawasaki Disease: A Cross-sectional Study. سامانه مدیریت نشریات علمی, 47(4), 379-384. doi: 10.30476/ijms.2021.90005.2079
Abdolreza Malek; Alireza Ghodsi; Abdolkarim Hamedi. "The Negative Predictive Value of Harada Scoring for Coronary Artery Dilatation or Aneurysm in Children with Kawasaki Disease: A Cross-sectional Study". سامانه مدیریت نشریات علمی, 47, 4, 1401, 379-384. doi: 10.30476/ijms.2021.90005.2079
Malek, Abdolreza, Ghodsi, Alireza, Hamedi, Abdolkarim. (1401). 'The Negative Predictive Value of Harada Scoring for Coronary Artery Dilatation or Aneurysm in Children with Kawasaki Disease: A Cross-sectional Study', سامانه مدیریت نشریات علمی, 47(4), pp. 379-384. doi: 10.30476/ijms.2021.90005.2079
Malek, Abdolreza, Ghodsi, Alireza, Hamedi, Abdolkarim. The Negative Predictive Value of Harada Scoring for Coronary Artery Dilatation or Aneurysm in Children with Kawasaki Disease: A Cross-sectional Study. سامانه مدیریت نشریات علمی, 1401; 47(4): 379-384. doi: 10.30476/ijms.2021.90005.2079

The Negative Predictive Value of Harada Scoring for Coronary Artery Dilatation or Aneurysm in Children with Kawasaki Disease: A Cross-sectional Study

Iranian Journal of Medical Sciences
مقاله 11، دوره 47، شماره 4، مهر 2022، صفحه 379-384    اصل مقاله (284.96 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2021.90005.2079
نویسندگان
Abdolreza Malek1؛ Alireza Ghodsi2؛ Abdolkarim Hamedi* 3
1Department of Pediatrics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
2Student Research Committee, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
3Infection Control Hand and Hygiene Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
چکیده
Background: The most common cause of coronary artery aneurysms in children is Kawasaki disease (KD). One of the risk ratings used to predict coronary artery aneurysms is the Harada score. This study aims to assess the negative predictive value (NPV) of Harada scoring in children with KD.
Methods: This cross-sectional study was conducted in Mashhad (Iran) from January 2014 to December 2017. The Harada score was generated for each patient using demographic, laboratory, and echocardiography data retrieved from their medical records.  The patients were divided into typical and atypical cases, and the sensitivity, specificity, positive predictive value (PPV), and NPV were calculated. The Chi square test, independent t test, Mann–Whitney U test, and Fisher exact test were used to analyze the data in SPSS software (version 23.0). P≤0.05 was considered statistically significant.
Results: The study involved 168 individuals with a mean age of 29.91±19.52 months, including 103 typical and 65 atypical cases. Regarding cardiac complications, the atypical group had a significantly greater rate of coronary artery tapering (P=0.030). Out of 101 patients with cardiac complications, the Harada score was positive in 57 cases, while it was falsely negative in the remaining 44 patients. The calculated sensitivity, specificity, PPV, and NPV were 56.44%, 53.73%, 64.77%, and 45%, respectively. 
Conclusion: The findings revealed that the Harada scoring is ineffective in detecting coronary artery aneurysms or dilation in KD patients.
کلیدواژه‌ها
Mucocutaneous lymph node syndrome؛ Coronary aneurysm؛ Predictive value of tests؛ Children
سایر فایل های مرتبط با مقاله
مراجع
  1. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation. 2017;135:e927-e99. doi: 10.1161/CIR.0000000000000484. PubMed PMID: 28356445.
  2. Rife E, Gedalia A. Kawasaki Disease: an Update. Curr Rheumatol Rep. 2020;22:75. doi: 10.1007/s11926-020-00941-4. PubMed PMID: 32924089; PubMed Central PMCID: PMCPMC7487199.
  3. Modesti AM, Plewa MC. Kawasaki Disease. StatPearls: StatPearls Publishing; 2019.
  4. Kim GB. Reality of Kawasaki disease epidemiology. Korean J Pediatr. 2019;62:292-6. doi: 10.3345/kjp.2019.00157. PubMed PMID: 31319643; PubMed Central PMCID: PMCPMC6702118.
  5. Vervoort D, Donne M, Van Gysel D. Pitfalls in the diagnosis and management of Kawasaki disease: An update for the pediatric dermatologist. Pediatr Dermatol. 2018;35:743-7. doi: 10.1111/pde.13620. PubMed PMID: 30338568.
  6. Marchesi A, Tarissi de Jacobis I, Rigante D, Rimini A, Malorni W, Corsello G, et al. Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase. Ital J Pediatr. 2018;44:102. doi: 10.1186/s13052-018-0536-3. PubMed PMID: 30157897; PubMed Central PMCID: PMCPMC6116535.
  7. Zhang D, Liu L, Huang X, Tian J. Insights Into Coronary Artery Lesions in Kawasaki Disease. Front Pediatr. 2020;8:493. doi: 10.3389/fped.2020.00493. PubMed PMID: 32984207; PubMed Central PMCID: PMCPMC7477115.
  8. de Ferranti SD, Gauvreau K, Friedman KG, Tang A, Baker AL, Fulton DR, et al. Association of Initially Normal Coronary Arteries With Normal Findings on Follow-up Echocardiography in Patients With Kawasaki Disease. JAMA Pediatr. 2018;172:e183310. doi: 10.1001/jamapediatrics.2018.3310. PubMed PMID: 30285057; PubMed Central PMCID: PMCPMC6583021.
  9. Burns JC, Franco A. The immunomodulatory effects of intravenous immunoglobulin therapy in Kawasaki disease. Expert Rev Clin Immunol. 2015;11:819-25. doi: 10.1586/1744666X.2015.1044980. PubMed PMID: 26099344; PubMed Central PMCID: PMCPMC4985263.
  10. Aoyagi R, Hamada H, Sato Y, Suzuki H, Onouchi Y, Ebata R, et al. Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial). BMJ Open. 2015;5:e009562. doi: 10.1136/bmjopen-2015-009562. PubMed PMID: 26628527; PubMed Central PMCID: PMCPMC4679944.
  11. Marrani E, Burns JC, Cimaz R. How Should We Classify Kawasaki Disease? Front Immunol. 2018;9:2974. doi: 10.3389/fimmu.2018.02974. PubMed PMID: 30619331; PubMed Central PMCID: PMCPMC6302019.
  12. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn. 1991;33:805-10. doi: 10.1111/j.1442-200x.1991.tb02612.x. PubMed PMID: 1801561.
  13. Rigante D, Andreozzi L, Fastiggi M, Bracci B, Natale MF, Esposito S. Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome. Int J Mol Sci. 2016;17:278. doi: 10.3390/ijms17030278. PubMed PMID: 26927060; PubMed Central PMCID: PMCPMC4813142.
  14. Kobayashi T. Other Challenging Therapies. Kawasaki: Springer; 2017. p. 195-8.
  15. Tewelde H, Yoon J, Van Ittersum W, Worley S, Preminger T, Goldfarb J. The Harada score in the US population of children with Kawasaki disease. Hosp Pediatr. 2014;4:233-8. doi: 10.1542/hpeds.2014-0008. PubMed PMID: 24986993.
  16. Mohammadzadeh I, Noei S, Babazadeh K, Zamani H, Barari-Savadkoohi R, Alizadeh-Navaei R. Comparison of early and late intravenous gamma globulin treatment of Kawasaki disease on fever and cardiovascular complications. Caspian J Intern Med. 2016;7:211-6. PubMed PMID: 27757208; PubMed Central PMCID: PMCPMC5062181. 
  17. Raeeskarami SR, Tahghighi F, Ziaee BAH, Assari R, Ziaee V, Aghighi Y, et al. Role of Kobayashi risk scoring for determining refractory Kawasaki disease. Journal of Comprehensive Pediatrics. 2018;9. doi: 10.5812/compreped.67116.
  18. MR, Mohammadi H, Mehdizadegan N, Ghorashi M, Amoozgar H, Borzouee M, et al. Japanese Kawasaki Disease Scoring Systems: Are they Applicable to the Iranian Population? Arch Iran Med. 2020;23:31-6. PubMed PMID: 31910632. 
  19. Mori M, Imagawa T, Yasui K, Kanaya A, Yokota S. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr. 2000;137:177-80. doi: 10.1067/mpd.2000.107890. PubMed PMID: 10931408.
  20. Kobayashi T, Inoue Y, Tamura K, Morikawa A, Kobayashi T. External validation of a scoring system to predict resistance to intravenous immunoglobulin. J Pediatr. 2007;150:e37. doi: 10.1016/j.jpeds.2006.12.036. PubMed PMID: 17382098.
  21. Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149:237-40. doi: 10.1016/j.jpeds.2006.03.050. PubMed PMID: 16887442.
  22. Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, et al. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007;166:131-7. doi: 10.1007/s00431-006-0223-z. PubMed PMID: 16896641.
  23. Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113:2606-12. doi: 10.1161/CIRCULATIONAHA.105.592865. PubMed PMID: 16735679.
آمار
تعداد مشاهده مقاله: 2,528
تعداد دریافت فایل اصل مقاله: 2,323


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب